TENNOR THERAPEUTICS LIMITED

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
C07D HETEROCYCLIC COMPOUNDS 11151
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
7884099 Quinolone carboxylic acid-substituted rifamycin derivativesNov 12, 08Feb 08, 11[A61K, C07D]
7678791 Nitroheteroaryl-containing rifamycin derivativesJul 12, 07Mar 16, 10[A61K, C07D, A61P]
7666864 Bicyclic nitroimidazole-substituted phenyl oxazolidinonesMar 25, 09Feb 23, 10[A61K, C07D]
7265107 Rifamycin C-11 oxime cyclo derivatives effective against drug-resistant microbesMar 09, 05Sep 04, 07[C07D]
7256187 Rifamycin C-11 oxime derivatives effective against drug-resistant microbesMar 09, 05Aug 14, 07[C07D]
7250413 C-25 carbamate rifamycin derivatives with activity against drug-resistant microbesApr 26, 05Jul 31, 07[C07D]
7247634 Rifamycin derivatives effective against drug-resistant microbesJan 12, 05Jul 24, 07[C07D]
7238694 Rifamycin imino derivatives effective against drug-resistant microbesJan 12, 05Jul 03, 07[C07D]
7229996 Rifamycin derivativesJul 21, 05Jun 12, 07[C07D]
7226931 (R/S) rifamycin derivatives, their preparations and pharmaceutical compositionsJul 21, 05Jun 05, 07[C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
5635349 High-throughput screening assay for inhibitors of nucleic acid polymerasesExpiredDec 02, 94Jun 03, 97[C07H, C12Q, C12P]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.